CEFTAZIDIME VIATRIS for children and for infants 250 mg, powder for solution for injection (IM, IV) 5 bottles
Active ingredients: Anhydrous ceftazidime, Ceftazidime pentahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injection5 bottlesintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFTAZIDIME VIATRIS ENFANTS ET NOURRISSONS 250 mg, poudre pour solution injectable (IM, IV)
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 5 flacon(s) en verre
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Dec 2007
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66064046CIP75714170CIP133400957141707Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CEFTAZIDIME PENTAHYDRATÉEpoudre | — | SA |
| CEFTAZIDIME ANHYDREpoudre | 250 mg · un flacon de poudre | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.